HUP0004565A2 - Szubsztituált krománszármazékok, intermedierjeik és azokat tartalmazó gyógyszerkészítmények - Google Patents
Szubsztituált krománszármazékok, intermedierjeik és azokat tartalmazó gyógyszerkészítményekInfo
- Publication number
- HUP0004565A2 HUP0004565A2 HU0004565A HUP0004565A HUP0004565A2 HU P0004565 A2 HUP0004565 A2 HU P0004565A2 HU 0004565 A HU0004565 A HU 0004565A HU P0004565 A HUP0004565 A HU P0004565A HU P0004565 A2 HUP0004565 A2 HU P0004565A2
- Authority
- HU
- Hungary
- Prior art keywords
- general formula
- chroman derivatives
- intermediates
- new
- alkyl
- Prior art date
Links
- 239000000543 intermediate Substances 0.000 title abstract 2
- VZWXIQHBIQLMPN-UHFFFAOYSA-N chromane Chemical class C1=CC=C2CCCOC2=C1 VZWXIQHBIQLMPN-UHFFFAOYSA-N 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 abstract 2
- -1 carboxyl-substituted chroman Chemical class 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 2
- 125000000027 (C1-C10) alkoxy group Chemical group 0.000 abstract 1
- 125000006569 (C5-C6) heterocyclic group Chemical group 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 230000001270 agonistic effect Effects 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000001188 haloalkyl group Chemical group 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000004043 oxo group Chemical group O=* 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
- Peptides Or Proteins (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Pyrrole Compounds (AREA)
- Detergent Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
A találmány tárgya új <3 adrenoreceptor agonista hatású karboxil-szubsztituált krománszármazékok, amelyekkel <-3 receptor általelőidézett állapotok kezelhetők. Az új karboxil-szubsztituáltkrománszármazékok az (I) általános képlettel jellemezhetők - ahol Rjelentése hidrogén- vagy halogénatom, hidroxil-, oxo-, 1-10 szénatomoshalogén-alkil-, 1-10 szénatomos alkil-, ciano-, nitro-, NR1R1, SR1,OR1, SO2R2, OCOR2, NR1COR2, COR2, NR1SO2R2, NR1CO2R1 vagy 1-10szénatomos alkil-, fenil-, pirrol- vagy 5-6-tagú heterociklusos gyűrű,amely 1-4 heteroatomot, mégpedig oxigén-, kén- és/vagy nitrogénatomottartalmaz. R3 jelentése hidrogénatom, 1-10 szénatomos alkil-, CO2R1vagy R-Ar1-CHOH-CH2- csoport; Ar1 jelentése fenil- vagy 5-6-tagú, 1-4heteroatomot, mégpedig oxigén-, kén- és/vagy nitrogénatomot tartalmazóheterociklusos gyűrű m értéke 1, 2 vagy 3; n értéke egymástólfüggetlenül 0, 1 vagy 2; X jelentése adott esetben halogénatommalszubsztituált 1-4 szénatomos alkilcsoport; R4 jelentése hidroxil-, 1-10 szénatomos alkoxi-, O-R1 vagy NR1R1 képletű csoport. A találmánykiterjed az új vegyületek előállításához hasznos (2) általános képletűintermedierekre és az (I) általános képletű vegyületekből kaphatógyógyszerkészítményekre is. Ó
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US99462097A | 1997-12-19 | 1997-12-19 | |
| PCT/US1998/026735 WO1999032476A1 (en) | 1997-12-19 | 1998-12-16 | Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0004565A2 true HUP0004565A2 (hu) | 2001-08-28 |
| HUP0004565A3 HUP0004565A3 (en) | 2002-12-28 |
Family
ID=25540853
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0004565A HUP0004565A3 (en) | 1997-12-19 | 1998-12-16 | Substituted chroman derivatives, their intermediates and medicines containing the same |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1040106B1 (hu) |
| JP (1) | JP2001526282A (hu) |
| KR (1) | KR20010033188A (hu) |
| CN (1) | CN1284952A (hu) |
| AT (1) | ATE222901T1 (hu) |
| AU (1) | AU749097B2 (hu) |
| BG (1) | BG104593A (hu) |
| BR (1) | BR9814302A (hu) |
| CA (1) | CA2316971A1 (hu) |
| DE (1) | DE69807523T2 (hu) |
| DK (1) | DK1040106T3 (hu) |
| ES (1) | ES2183434T3 (hu) |
| HU (1) | HUP0004565A3 (hu) |
| ID (1) | ID26524A (hu) |
| IL (1) | IL136689A0 (hu) |
| NO (1) | NO20003083L (hu) |
| NZ (1) | NZ505200A (hu) |
| PL (1) | PL341229A1 (hu) |
| PT (1) | PT1040106E (hu) |
| RU (1) | RU2223269C2 (hu) |
| SK (1) | SK9362000A3 (hu) |
| TR (1) | TR200001927T2 (hu) |
| UA (1) | UA62993C2 (hu) |
| WO (1) | WO1999032476A1 (hu) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR035605A1 (es) * | 2000-12-11 | 2004-06-16 | Bayer Corp | Derivados de aminometil cromano di-sustituidos, un metodo para su preparacion, composiciones farmaceuticas y el uso de dichos derivados para la manufactura de medicamentos utiles como agonistas beta-3-adreno-receptores |
| AR035858A1 (es) * | 2001-04-23 | 2004-07-21 | Bayer Corp | Derivados de cromano 2,6-sustituidos,composiciones farmaceuticas,uso de dichos derivados para la manufactura de medicamentos utiles como agonistas adrenorreceptores beta-3 |
| US20040265991A1 (en) * | 2001-10-17 | 2004-12-30 | Naoaki Taoka | Process for preparation of (s)-alpha-halomethylpyridine-methanol derivatives |
| MY147767A (en) * | 2004-06-16 | 2013-01-31 | Janssen Pharmaceutica Nv | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
| GT200600078A (es) | 2005-02-17 | 2007-04-12 | Derivados de indol, benzotiofeno, benzofurano e indeno cicloalquil condensados | |
| EP1803716B1 (en) * | 2005-12-28 | 2012-07-25 | Acino Pharma AG | A process for preparation of racemic nebivolol |
| US7560575B2 (en) | 2005-12-28 | 2009-07-14 | Acino Pharma Ag | Process for preparation of racemic Nebivolol |
| ES2534318B1 (es) * | 2013-10-18 | 2016-01-28 | Artax Biopharma Inc. | Derivados de cromeno sustituidos por alcóxido como inhibidores de la interacción TCR-Nck |
| ES2534336B1 (es) * | 2013-10-18 | 2016-01-28 | Artax Biopharma Inc. | Derivados de cromeno como inhibidores de la interacción TCR-Nck |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1337429C (en) * | 1983-12-05 | 1995-10-24 | Guy Rosalia Eugene Van Lommen | Derivatives of 2,2'-iminobisethanol |
| GB8801306D0 (en) * | 1988-01-21 | 1988-02-17 | Ici Plc | Chemical compounds |
| US5451677A (en) * | 1993-02-09 | 1995-09-19 | Merck & Co., Inc. | Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity |
| CA2164009A1 (en) * | 1993-06-14 | 1994-12-22 | Robert L. Dow | Secondary amines as antidiabetic and antiobesity agents |
| GB9405019D0 (en) * | 1994-03-15 | 1994-04-27 | Smithkline Beecham Plc | Novel compounds |
| US5561142A (en) * | 1994-04-26 | 1996-10-01 | Merck & Co., Inc. | Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity |
| EP0801060A1 (en) * | 1996-04-09 | 1997-10-15 | Pfizer Inc. | Heterocyclic Beta-3 Adrenergenic Agonists |
-
1998
- 1998-12-16 UA UA2000074336A patent/UA62993C2/uk unknown
- 1998-12-16 AT AT98963240T patent/ATE222901T1/de not_active IP Right Cessation
- 1998-12-16 ID IDW20001393A patent/ID26524A/id unknown
- 1998-12-16 KR KR1020007006572A patent/KR20010033188A/ko not_active Application Discontinuation
- 1998-12-16 PT PT98963240T patent/PT1040106E/pt unknown
- 1998-12-16 DK DK98963240T patent/DK1040106T3/da active
- 1998-12-16 IL IL13668998A patent/IL136689A0/xx unknown
- 1998-12-16 AU AU18300/99A patent/AU749097B2/en not_active Ceased
- 1998-12-16 NZ NZ505200A patent/NZ505200A/xx unknown
- 1998-12-16 CN CN98813619A patent/CN1284952A/zh active Pending
- 1998-12-16 WO PCT/US1998/026735 patent/WO1999032476A1/en not_active Application Discontinuation
- 1998-12-16 TR TR2000/01927T patent/TR200001927T2/xx unknown
- 1998-12-16 DE DE69807523T patent/DE69807523T2/de not_active Expired - Fee Related
- 1998-12-16 PL PL98341229A patent/PL341229A1/xx not_active Application Discontinuation
- 1998-12-16 RU RU2000119110/04A patent/RU2223269C2/ru not_active IP Right Cessation
- 1998-12-16 EP EP98963240A patent/EP1040106B1/en not_active Expired - Lifetime
- 1998-12-16 BR BR9814302-6A patent/BR9814302A/pt not_active IP Right Cessation
- 1998-12-16 HU HU0004565A patent/HUP0004565A3/hu unknown
- 1998-12-16 ES ES98963240T patent/ES2183434T3/es not_active Expired - Lifetime
- 1998-12-16 JP JP2000525413A patent/JP2001526282A/ja not_active Withdrawn
- 1998-12-16 SK SK936-2000A patent/SK9362000A3/sk unknown
- 1998-12-16 CA CA002316971A patent/CA2316971A1/en not_active Abandoned
-
2000
- 2000-06-15 NO NO20003083A patent/NO20003083L/no not_active Application Discontinuation
- 2000-07-11 BG BG104593A patent/BG104593A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69807523T2 (de) | 2003-01-09 |
| IL136689A0 (en) | 2001-06-14 |
| ES2183434T3 (es) | 2003-03-16 |
| TR200001927T2 (tr) | 2001-06-21 |
| CA2316971A1 (en) | 1999-07-01 |
| NO20003083D0 (no) | 2000-06-15 |
| PT1040106E (pt) | 2002-11-29 |
| ID26524A (id) | 2001-01-11 |
| EP1040106A1 (en) | 2000-10-04 |
| NZ505200A (en) | 2002-09-27 |
| KR20010033188A (ko) | 2001-04-25 |
| UA62993C2 (en) | 2004-01-15 |
| AU749097B2 (en) | 2002-06-20 |
| SK9362000A3 (en) | 2001-09-11 |
| NO20003083L (no) | 2000-08-15 |
| PL341229A1 (en) | 2001-03-26 |
| DE69807523D1 (de) | 2002-10-02 |
| BR9814302A (pt) | 2000-10-10 |
| DK1040106T3 (da) | 2002-12-02 |
| CN1284952A (zh) | 2001-02-21 |
| RU2223269C2 (ru) | 2004-02-10 |
| EP1040106B1 (en) | 2002-08-28 |
| AU1830099A (en) | 1999-07-12 |
| JP2001526282A (ja) | 2001-12-18 |
| HUP0004565A3 (en) | 2002-12-28 |
| BG104593A (en) | 2001-09-28 |
| ATE222901T1 (de) | 2002-09-15 |
| WO1999032476A1 (en) | 1999-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0000079A2 (hu) | Indán- és dihidroindolszármazékok | |
| HUP9802859A2 (hu) | Acil-amino-szalicilsav-amid-származékok és alkalmazásuk peszticidként | |
| HUP9902471A2 (hu) | Piperazin- és piperidinvegyületek, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények | |
| DK0915866T3 (da) | Forbedret fremgangsmåde til syntese af beskyttende estere af (S)-3,4-dihydroxysmørsyre | |
| HUP9802417A2 (hu) | Heteroaril-csoportot tartalmazó amidszármazékok, valamint ezeket a vegyületeket tartalmazó gyógyászati készítmények | |
| HUP0001192A2 (hu) | Topiramát és származékainak alkalmazása elhízás kezelésére használható gyógyszerkészítmények előállítására | |
| UA48937C2 (uk) | Імідазолідини, заміщені гетероциклом, спосіб їх одержання і фармацевтична композиція, що їх містить | |
| ES2188016T3 (es) | Derivaqdo de benzamidoxima, productos intermedios y procedimiento para su obtencion y su empleo como fungicidas. | |
| HUP0300207A2 (en) | 1,2,3,4-tetrahydroisquinoline derivatives, pharmaceutical compositions containing them and their preparation processes | |
| HUP9800295A2 (hu) | Szubsztituált heterociklusos vegyületek, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények, intermedierjeik | |
| KR100263496B1 (ko) | 탁솔 유도체 및 이의 제조방법 | |
| HUP9700779A1 (hu) | Ösztrogén vegyületek, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| DE69738740D1 (de) | Verwendung von Oestrogen Antagonisten und Oestrogen Agonisten zur Behandlung von pathologischen Zuständen | |
| HUP9700328A2 (hu) | Heteroaril-oxazolidinonok, eljárás előállításukra, a vegyületeket tartalmazó gyógyszerkészítmények, alkalmazásuk és köztitermékeik | |
| ES2150353A1 (es) | Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos. | |
| DE60009910D1 (de) | Verfahren zur herstellung von zsm-5 und zsm-11 | |
| HUP0004565A2 (hu) | Szubsztituált krománszármazékok, intermedierjeik és azokat tartalmazó gyógyszerkészítmények | |
| HUP9802257A2 (hu) | Szelektív béta3 adrenerg agonisták, előállításuk és a vegyületeket tartalmazó gyógyszerkészítmények | |
| ES2073258T3 (es) | Nuevos derivados de la urea, su preparacion y su aplicacion en terapeutica. | |
| AU2001293804A1 (en) | New benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors | |
| MXPA02012569A (es) | Ftalidas substituidas novedosas, un procedimiento para su preparacion y las composiciones farmaceuticas que contienen a las mismas. | |
| EA200000484A1 (ru) | Способ получения производных тиазолидиндиона | |
| HUP9901212A2 (hu) | N,N-dialkil-N-[2-(3-alkoxi-fenoxi)-etil]-amin-származékok, az ezeket tartalmazó gyógyszerkészítmények és helyi érzéstelenítőkként való alkalmazásuk | |
| ES2106936T3 (es) | Derivados de carbazolona y procedimientos para su preparacion. | |
| ES2008962A6 (es) | Proceso para la preparacion de nuevos compuestos de 2-guanidinotiazol |